Point of Care (POC) Blood Gas and Electrolyte Market Trends and Forecast 2024-2028

The point of care blood gas and electrolyte market is projected to grow by USD 385 million at a CAGR of 7.08% between 2023 and 2028.The market is witnessing strong growth due to factors such as an aging population in North America, which increases demand for frequent monitoring of blood gases and electrolyte levels. A notable trend is the shift from benchtop to portable POC devices, enhancing mobility and convenience for healthcare professionals and patients. Stringent government regulations ensuring accuracy and safety further contribute to market expansion.The market includes devices and consumables used to measure electrolytes and metabolites like lactate at the point of care. These measurements are essential for diagnosing and managing conditions such as diabetes and chronic bronchitis. Blood gas analyzers play a crucial role in determining pH levels and assessing respiratory acidosis or alkalosis. Electronic medical records and critical care units are key demand drivers, alongside increasing ventilator use in pulmonary units, neonatal intensive care, and emergency rooms.

For more details about the industry, get the PDF sample report for free

Market Segmentation

By Product

• Consumables
• Instruments

By Geography

• North America

  • Canada

  • US

• Europe

  • Germany

  • UK

• Asia

  • China

• Rest of World (ROW)

Segment Insights

By Product Insights

The consumables segment is expected to witness significant growth during the forecast period.The market includes instruments, consumables, and blood samples for analyzing blood gases, pH levels, electrolytes, metabolites, and biochemical markers. The consumables segment dominates the market due to the rising prevalence of chronic diseases such as diabetes and cardiovascular diseases (CVDs), necessitating frequent electrolyte tests. This drives demand for consumables like cartridges, test strips, electrodes, and controls.

POC testing is widely adopted in ICUs, emergency departments, hospitals, and clinics. Electrolyte imbalances, blood pressure, heart rate, rhythm, and respiration rate measurements are crucial in critical care units, ICUs, burn units, trauma units, chest pain units, stroke units, operating rooms, ambulances, and other healthcare facilities.

Portable and benchtop devices, CO-oximetry, and wireless POC devices enhance the efficiency of electrolyte assessments.The consumables segment was valued at USD 552.90 million in 2018 and has shown a steady increase over the years.

Regional Market Trends

• North America

  • The US and Canada are major contributors to revenue growth.
  • Market expansion is driven by a rising prevalence of chronic diseases such as diabetes and chronic bronchitis.
  • FDA approvals for new analyzers and electrolyte analyzers support commercialization.

• Europe

  • The region is expected to contribute 37% of global market growth.

• Asia

  • China remains a key market within the region.

• Rest of the World (ROW)

  • Includes emerging markets adopting POC testing solutions.

Market Dynamics

Key Market Drivers

• Rising geriatric population

  • Increasing elderly demographics lead to higher demand for frequent electrolyte and blood gas monitoring.
  • POC devices are increasingly used in home care settings.

• Prevalence of chronic diseases

  • The growing cases of diabetes, chronic bronchitis, and cancer require continuous monitoring of biochemical markers.
  • POC testing plays a crucial role in ICUs, burn units, trauma units, and operating rooms.

• Integration with other healthcare systems

  • Adoption of electronic medical records and hybrid operating rooms contributes to market growth.

Market Trends

• Paradigm shift from benchtop to portable POC devices

  • The demand for portable and benchtop devices, including blood gas analyzers and CO-oximetry systems, is increasing due to convenience and cost-effectiveness.
  • Wireless point-of-care devices are gaining traction.

• Increasing demand for rapid and accurate testing solutions

  • POC blood gas and electrolyte testing enables quick assessment of pH, electrolytes, metabolites, and biochemical markers.
  • The rising prevalence of lifestyle diseases such as obesity fuels market growth.

Market Challenges

• Stringent government regulations

  • Regulatory approvals, such as FDA’s 501(k) clearance, are required for market entry.
  • Compliance with varying international standards creates challenges for manufacturers.

• Concerns over testing variability and infection risks

  • The use of multiple POC test products may result in inconsistent test results.
  • Infection risks require strict regulatory compliance.

Get more details by ordering the complete report

Key Players

• Abbott Laboratories
• Bayer AG
• Biobase Biodusty Shandong Co. Ltd.
• Convergent Technologies GmbH and Co. KG
• Danaher Corp.
• EDAN Instruments Inc.
• F. Hoffmann La Roche Ltd.
• Fortress Diagnostics
• Guangzhou MeCan Medical Ltd.
• Guangzhou Yueshen Medical Equipment Co. Ltd.
• IDEXX Laboratories Inc.
• JOKOH CO. LTD.
• LIFEHEALTH LLC
• Medica Corp.
• Nova Biomedical Corp.
• Radiometer Medical ApS
• Shinova Medical Co. Ltd.
• Siemens Healthineers AG
• TECOM Analytical Systems
• Werfenlife SA

Future Market Insights

The POC blood gas and electrolyte market is expected to witness substantial growth driven by increasing demand for rapid, accurate, and cost-effective diagnostic solutions. The shift toward portable and wireless devices, along with the integration of electronic medical records and home care applications, will further support market expansion. The industry will continue evolving, influenced by regulatory developments and technological advancements in blood gas and electrolyte testing systems.